{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:12:23Z","timestamp":1789711943841,"version":"4.0.1"},"reference-count":67,"publisher":"American Society for Microbiology","issue":"4","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2007,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>To elucidate critical components of protective immune responses induced during the natural course of serogroup A meningococcal disease, we studied acute-, early-convalescent-, and late-convalescent-phase sera from Ethiopian patients during outbreaks in 2002 to 2003. Sera were obtained from laboratory-confirmed patients positive for serogroup A sequence type 7 (ST-7) meningococci (A:4\/21:P1.20,9) (<jats:italic>n<\/jats:italic>= 71) and from Ethiopian controls (<jats:italic>n<\/jats:italic>= 113). The sera were analyzed using an enzyme-linked immunosorbent assay to measure levels of immunoglobulin G (IgG) against serogroup A polysaccharide (APS) and outer membrane vesicles (OMVs) and for serum bactericidal activity (SBA) using both rabbit and human complement sources. Despite relatively high SBA titers and high levels of IgG against APS and OMVs in acute-phase patient sera, significant increases were seen in the early convalescent phase. Antibody concentrations returned to acute-phase levels in the late convalescent phase. Considering all patients' sera, a significant but low correlation (<jats:italic>r<\/jats:italic>= 0.46) was observed between SBA with rabbit complement (rSBA) using an ST-5 reference strain and SBA with human complement (hSBA) using an ST-7 strain from Ethiopia. While rSBA demonstrated a significant linear relation with IgG against APS, hSBA demonstrated significant linear relationships with IgG against both APS and OMV. This study indicates that antibodies against both outer membrane proteins and APS may be important in providing the protection induced during disease, as measured by hSBA. Therefore, outer membrane proteins could also have a role as components of future meningococcal vaccines for the African meningitis belt.<\/jats:p>","DOI":"10.1128\/cvi.00008-07","type":"journal-article","created":{"date-parts":[[2007,2,15]],"date-time":"2007-02-15T01:37:39Z","timestamp":1171503459000},"page":"451-463","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":10,"title":["Serum Antibody Responses in Ethiopian Meningitis Patients Infected with<i>Neisseria meningitidis<\/i>Serogroup A Sequence Type 7"],"prefix":"10.1128","volume":"14","author":[{"given":"Gunnstein","family":"Norheim","sequence":"first","affiliation":[{"name":"Division of Infectious Disease Control, Norwegian Institute of Public Health (NIPH)"},{"name":"Department of Oral Biology, University of Oslo"},{"name":"Institute of Immunology, University of Oslo, and Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway"},{"name":"Armauer Hansen Research Institute (AHRI)"},{"name":"Department of Internal Medicine, Faculty of Medicine, Addis Ababa University, Addis Ababa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Aseffa","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease Control, Norwegian Institute of Public Health (NIPH)"},{"name":"Department of Oral Biology, University of Oslo"},{"name":"Institute of Immunology, University of Oslo, and Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway"},{"name":"Armauer Hansen Research Institute (AHRI)"},{"name":"Department of Internal Medicine, Faculty of Medicine, Addis Ababa University, Addis Ababa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Ahmed","family":"Yassin","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease Control, Norwegian Institute of Public Health (NIPH)"},{"name":"Department of Oral Biology, University of Oslo"},{"name":"Institute of Immunology, University of Oslo, and Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway"},{"name":"Armauer Hansen Research Institute (AHRI)"},{"name":"Department of Internal Medicine, Faculty of Medicine, Addis Ababa University, Addis Ababa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getahun","family":"Mengistu","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease Control, Norwegian Institute of Public Health (NIPH)"},{"name":"Department of Oral Biology, University of Oslo"},{"name":"Institute of Immunology, University of Oslo, and Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway"},{"name":"Armauer Hansen Research Institute (AHRI)"},{"name":"Department of Internal Medicine, Faculty of Medicine, Addis Ababa University, Addis Ababa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afework","family":"Kassu","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease Control, Norwegian Institute of Public Health (NIPH)"},{"name":"Department of Oral Biology, University of Oslo"},{"name":"Institute of Immunology, University of Oslo, and Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway"},{"name":"Armauer Hansen Research Institute (AHRI)"},{"name":"Department of Internal Medicine, Faculty of Medicine, Addis Ababa University, Addis Ababa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dereje","family":"Fikremariam","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease Control, Norwegian Institute of Public Health (NIPH)"},{"name":"Department of Oral Biology, University of Oslo"},{"name":"Institute of Immunology, University of Oslo, and Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway"},{"name":"Armauer Hansen Research Institute (AHRI)"},{"name":"Department of Internal Medicine, Faculty of Medicine, Addis Ababa University, Addis Ababa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wegene","family":"Tamire","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease Control, Norwegian Institute of Public Health (NIPH)"},{"name":"Department of Oral Biology, University of Oslo"},{"name":"Institute of Immunology, University of Oslo, and Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway"},{"name":"Armauer Hansen Research Institute (AHRI)"},{"name":"Department of Internal Medicine, Faculty of Medicine, Addis Ababa University, Addis Ababa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yared","family":"Merid","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease Control, Norwegian Institute of Public Health (NIPH)"},{"name":"Department of Oral Biology, University of Oslo"},{"name":"Institute of Immunology, University of Oslo, and Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway"},{"name":"Armauer Hansen Research Institute (AHRI)"},{"name":"Department of Internal Medicine, Faculty of Medicine, Addis Ababa University, Addis Ababa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Arne","family":"H\u00f8iby","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease Control, Norwegian Institute of Public Health (NIPH)"},{"name":"Department of Oral Biology, University of Oslo"},{"name":"Institute of Immunology, University of Oslo, and Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway"},{"name":"Armauer Hansen Research Institute (AHRI)"},{"name":"Department of Internal Medicine, Faculty of Medicine, Addis Ababa University, Addis Ababa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique A.","family":"Caugant","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease Control, Norwegian Institute of Public Health (NIPH)"},{"name":"Department of Oral Biology, University of Oslo"},{"name":"Institute of Immunology, University of Oslo, and Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway"},{"name":"Armauer Hansen Research Institute (AHRI)"},{"name":"Department of Internal Medicine, Faculty of Medicine, Addis Ababa University, Addis Ababa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Fritzs\u00f8nn","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease Control, Norwegian Institute of Public Health (NIPH)"},{"name":"Department of Oral Biology, University of Oslo"},{"name":"Institute of Immunology, University of Oslo, and Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway"},{"name":"Armauer Hansen Research Institute (AHRI)"},{"name":"Department of Internal Medicine, Faculty of Medicine, Addis Ababa University, Addis Ababa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torill","family":"Tangen","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease Control, Norwegian Institute of Public Health (NIPH)"},{"name":"Department of Oral Biology, University of Oslo"},{"name":"Institute of Immunology, University of Oslo, and Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway"},{"name":"Armauer Hansen Research Institute (AHRI)"},{"name":"Department of Internal Medicine, Faculty of Medicine, Addis Ababa University, Addis Ababa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsegaye","family":"Alebel","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease Control, Norwegian Institute of Public Health (NIPH)"},{"name":"Department of Oral Biology, University of Oslo"},{"name":"Institute of Immunology, University of Oslo, and Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway"},{"name":"Armauer Hansen Research Institute (AHRI)"},{"name":"Department of Internal Medicine, Faculty of Medicine, Addis Ababa University, Addis Ababa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Degu","family":"Berhanu","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease Control, Norwegian Institute of Public Health (NIPH)"},{"name":"Department of Oral Biology, University of Oslo"},{"name":"Institute of Immunology, University of Oslo, and Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway"},{"name":"Armauer Hansen Research Institute (AHRI)"},{"name":"Department of Internal Medicine, Faculty of Medicine, Addis Ababa University, Addis Ababa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Harboe","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease Control, Norwegian Institute of Public Health (NIPH)"},{"name":"Department of Oral Biology, University of Oslo"},{"name":"Institute of Immunology, University of Oslo, and Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway"},{"name":"Armauer Hansen Research Institute (AHRI)"},{"name":"Department of Internal Medicine, Faculty of Medicine, Addis Ababa University, Addis Ababa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einar","family":"Rosenqvist","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease Control, Norwegian Institute of Public Health (NIPH)"},{"name":"Department of Oral Biology, University of Oslo"},{"name":"Institute of Immunology, University of Oslo, and Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway"},{"name":"Armauer Hansen Research Institute (AHRI)"},{"name":"Department of Internal Medicine, Faculty of Medicine, Addis Ababa University, Addis Ababa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"754","volume":"81","year":"2003","unstructured":"Achtman, M. 2003. Successful prevention of meningitis in Africa will need more than a vaccination strategy. Bull. W. H. O.81:754-755.","journal-title":"Bull. W. H. O."},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/infdis\/165.1.53","volume":"165","year":"1992","unstructured":"Achtman, M., B. Kusecek, G. Morelli, K. Eickmann, J. F. Wang, B. Crowe, R. A. Wall, M. Hassan-King, P. S. Moore, and W. Zollinger. 1992. A comparison of the variable antigens expressed by clone IV-1 and subgroup III of Neisseria meningitidis serogroup A. J. Infect. Dis.165:53-68.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.5.2932-2939.2005"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.vaccine.2004.07.042","volume":"23","year":"2005","unstructured":"Amir, J., L. Louie, and D. M. Granoff. 2005. Naturally-acquired immunity to Neisseria meningitidis group A. Vaccine23:977-983.","journal-title":"Vaccine"},{"key":"e_1_3_2_6_2","first-page":"780","volume":"10","year":"2003","unstructured":"Andrews, N., R. Borrow, and E. Miller. 2003. Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England. Clin. Diagn. Lab. Immunol.10:780-786.","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/pmic.200400946","volume":"4","year":"2004","unstructured":"Bernardini, G., G. Renzone, M. Comanducci, R. Mini, S. Arena, C. D'Ambrosio, S. Bambini, L. Trabalzini, G. Grandi, P. Martelli, M. Achtman, A. Scaloni, G. Ratti, and A. Santucci. 2004. Proteome analysis of Neisseria meningitidis serogroup A. Proteomics4:2893-2926.","journal-title":"Proteomics"},{"key":"e_1_3_2_8_2","first-page":"289","year":"2001","unstructured":"Borrow, R., and G. M. Carlone. 2001. Serogroup B and C serum bactericidal assays, p. 289-304. In A. J. Pollard and M. C. Maiden (ed.), Methods in molecular medicine: meningococcal vaccines. Methods and protocols. Humana Press, Totowa, NJ.","journal-title":"Methods in molecular medicine: meningococcal vaccines"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1016\/S0264-410X(01)00050-0","volume":"19","year":"2001","unstructured":"Borrow, R., J. Southern, N. Andrews, N. Peake, R. Rahim, M. Acuna, S. Martin, E. Miller, and E. Kaczmarski. 2001. Comparison of antibody kinetics following meningococcal serogroup C conjugate vaccine between healthy adults previously vaccinated with meningococcal A\/C polysaccharide vaccine and vaccine-naive controls. Vaccine19:3043-3050.","journal-title":"Vaccine"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0264-410X(98)00257-6","volume":"17","year":"1999","unstructured":"Brieske, N., M. Schenker, T. Schnibbe, M. J. Quentin-Millet, and M. Achtman. 1999. Human antibody responses to A and C capsular polysaccharides, IgA1 protease and transferrin-binding protein complex stimulated by infection with Neisseria meningitidis of subgroup IV-1 or ET-37 complex. Vaccine17:731-744.","journal-title":"Vaccine"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/infdis\/166.6.1316","volume":"166","year":"1992","unstructured":"Brooks, G. F., C. J. Lammel, M. S. Blake, B. Kusecek, and M. Achtman. 1992. Antibodies against IgA1 protease are stimulated both by clinical disease and asymptomatic carriage of serogroup A Neisseria meningitidis. J. Infect. Dis.166:1316-1321.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.30.1.154-159.1992"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1016\/j.vaccine.2004.02.028","volume":"22","year":"2004","unstructured":"Chippaux, J. P., A. Garba, C. Ethevenaux, G. Campagne, F. de Chabalier, S. Djibo, P. Nicolas, H. Ali, M. Charrondiere, R. Ryall, M. Bybel, and A. Schuchat. 2004. Immunogenicity, safety, and memory of different schedules of Neisseria meningitidis A\/C-diphtheria toxoid conjugate vaccine in infants in Niger. Vaccine22:3303-3311.","journal-title":"Vaccine"},{"key":"e_1_3_2_14_2","first-page":"58","volume":"2000","year":"2000","unstructured":"Filatova, T. N., and L. N. Gamzulina. 2000. Antibodies to meningococcal antibodies in the sera of patients and donors. Zh. Mikrobiol. Epidemiol. Immunobiol.2000:58-62. (In Russian.)","journal-title":"Zh. Mikrobiol. Epidemiol. Immunobiol."},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1517\/14712598.5.2.273","volume":"5","year":"2005","unstructured":"Frasch, C. E. 2005. Recent developments in Neisseria meningitidis group A conjugate vaccines. Expert Opin. Biol. Ther.5:273-280.","journal-title":"Expert Opin. Biol. Ther."},{"key":"e_1_3_2_16_2","unstructured":"Fuglesang J. E. E. A. H\u00f8iby J. Holst E. Rosenqvist and H. N\u00f8kleby. 1998. Increased and longer-lasting immune responses to the Norwegian meningococcal group B OMV vaccine in teenagers with a three-dose compared to a two-dose regimen p. 174. Abstr. 11th Int. Pathogenic Neisseria Conf. Nice France 1 to 6 November 1998. E.D.K. Paris France."},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","volume":"129","year":"1969","unstructured":"Goldschneider, I., E. C. Gotschlich, and M. S. Artenstein. 1969. Human immunity to the meningococcus. I. The role of humoral antibodies. J. Exp. Med.129:1307-1326.","journal-title":"J. Exp. Med."},{"key":"e_1_3_2_18_2","first-page":"59","volume":"1981","year":"1981","unstructured":"Golovina, L. I., M. A. Smirnova-Mutusheva, A. I. Mishina, I. Vengerov, and M. E. Churkanova. 1981. Various aspects of humoral immunity in meningococcal infections. II. Formation of antibodies to group A meningococci in adults with generalized meningococcal infections. Zh. Mikrobiol. Epidemiol. Immunobiol.1981:59-63. (In Russian.)","journal-title":"Zh. Mikrobiol. Epidemiol. Immunobiol."},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1084\/jem.129.6.1367","volume":"129","year":"1969","unstructured":"Gotschlich, E. C., I. Goldschneider, and M. S. Artenstein. 1969. Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers. J. Exp. Med.129:1367-1384.","journal-title":"J. Exp. Med."},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1084\/jem.129.6.1349","volume":"129","year":"1969","unstructured":"Gotschlich, E. C., T. Y. Liu, and M. S. Artenstein. 1969. Human immunity to the meningococcus. III. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides. J. Exp. Med.129:1349-1365.","journal-title":"J. Exp. Med."},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0163-4453(87)92052-4","volume":"14","year":"1987","unstructured":"Greenwood, B. M., A. M. Greenwood, A. K. Bradley, K. Williams, M. Hassan-King, F. C. Shenton, R. A. Wall, and R. J. Hayes. 1987. Factors influencing susceptibility to meningococcal disease during an epidemic in The Gambia, West Africa. J. Infect.14:167-184.","journal-title":"J. Infect."},{"key":"e_1_3_2_22_2","first-page":"99","year":"1987","unstructured":"Griffiss, J. M., B. Brandt, and G. A. Jarvis. 1987. Natural immunity to Neisseria meningitidis, p. 99-119. In N. A. Vedros (ed.), Evolution of meningococcal disease, vol. II. CRC Press, Inc., Boca Raton, FL.","journal-title":"Evolution of meningococcal disease"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.24.6.947-953.1986"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.22.1.136-138.1985"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/cdli.2.2.132-137.1995"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/01.inf.0000135659.52662.a2","volume":"23","year":"2004","unstructured":"Ismail, A. A., S. L. Harris, and D. M. Granoff. 2004. Serum group A anticapsular antibodies in a Sudanese population immunized with meningococcal polysaccharide vaccine during a group A epidemic. Pediatr. Infect. Dis. J.23:748-755.","journal-title":"Pediatr. Infect. Dis. J."},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.4049\/jimmunol.147.6.1962","volume":"147","year":"1991","unstructured":"Jarvis, G. A., and J. M. Griffiss. 1991. Human IgA1 blockade of IgG-initiated lysis of Neisseria meningitidis is a function of antigen-binding fragment binding to the polysaccharide capsule. J. Immunol.147:1962-1967.","journal-title":"J. Immunol."},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/S0140-6736(03)13494-0","volume":"361","year":"2003","unstructured":"Jodar, L., F. M. LaForce, C. Ceccarini, T. Aguado, and D. M. Granoff. 2003. Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countries. Lancet361:1902-1904.","journal-title":"Lancet"},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1086\/322790","volume":"184","year":"2001","unstructured":"Joseph, H., E. Miller, M. Dawson, N. Andrews, I. Feavers, and R. Borrow. 2001. Meningococcal serogroup A avidity indices as a surrogate marker of priming for the induction of immunologic memory after vaccination with a meningococcal A\/C conjugate vaccine in infants in the United Kingdom. J. Infect. Dis.184:661-662.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1086\/368358","volume":"187","year":"2003","unstructured":"Joseph, H., R. Ryall, M. Bybel, T. Papa, J. MacLennan, J. Buttery, and R. Borrow. 2003. Immunogenicity and immunological priming of the serogroup A portion of a bivalent meningococcal A\/C conjugate vaccine in 2-year-old children. J. Infect. Dis.187:1142-1146.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-3024.1982.tb00428.x","volume":"4","year":"1982","unstructured":"Kayhty, H. 1982. The unspecific antibody response to N. meningitidis group A capsular polysaccharide often seen in bacteraemic diseases. Parasite Immunol.4:157-170.","journal-title":"Parasite Immunol."},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/infdis\/143.1.32","volume":"143","year":"1981","unstructured":"Kayhty, H., H. Jousimies-Somer, H. Peltola, and P. H. Maketa. 1981. Antibody response to capsular polysaccharides of groups A and C Neisseria meningitidis and Haemophilus influenzae type b during bacteremic disease. J. Infect. Dis.143:32-41.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_33_2","first-page":"2642","volume":"8","year":"2006","unstructured":"Kelly, D. F., M. D. Snape, E. A. Clutterbuck, S. Green, C. Snowden, L. Diggle, L. M. Yu, A. Borkowski, E. R. Moxon, and A. J. Pollard. 2006. CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells. Blood8:2642-2647.","journal-title":"Blood"},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1128\/CDLI.12.10.1251-1253.2005","volume":"12","year":"2005","unstructured":"Khalil, M., Y. Al Mazrou, P. Balmer, J. Bramwell, N. Andrews, and R. Borrow. 2005. Immunogenicity of meningococcal ACYW135 polysaccharide vaccine in Saudi children 5 to 9 years of age. Clin. Diagn. Lab. Immunol.12:1251-1253.","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"e_1_3_2_35_2","unstructured":"Kou J. 2004. Menactra meningococcal (groups A C Y and W135) polysaccharide diphtheria toxoid conjugate vaccine. FDA Statistical Review and Evaluation. Document for the Vaccines and Related Biological Products Advisory Committee. U.S. Food and Drug Administration Rockville MD. http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/04\/briefing\/4072B1_2b.doc ."},{"key":"e_1_3_2_36_2","first-page":"70","volume":"1986","year":"1986","unstructured":"Krasnoproshina, L. I., I. A. Alekseeva, I. Vengerov, I. Sokolov, and A. M. Gracheva. 1986. Dynamics of the level of antibodies to protein antigens of the meningococcus serogroup A in the serum of patients with meningococcal infection. Zh. Mikrobiol. Epidemiol. Immunobiol.1986:70-74. (In Russian.)","journal-title":"Zh. Mikrobiol. Epidemiol. Immunobiol."},{"key":"e_1_3_2_37_2","first-page":"3","volume":"28","year":"1963","unstructured":"Lapeyssonnie, L. 1963. Cerebrospinal meningitis in Africa. Bull. W. H. O.28(Suppl.):3-114. (In French.)","journal-title":"Bull. W. H. O."},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0003-2697(60)90020-8","volume":"1","year":"1960","unstructured":"Mandell, J. D., and A. D. Hershey. 1960. A fractionating column for analysis of nucleic acids. Anal. Biochem.1:66-77.","journal-title":"Anal. Biochem."},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/cdli.4.2.156-167.1997"},{"key":"e_1_3_2_40_2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/clinids\/14.2.515","volume":"14","year":"1992","unstructured":"Moore, P. S. 1992. Meningococcal meningitis in sub-Saharan Africa: a model for the epidemic process. Clin. Infect. Dis.14:515-525.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_41_2","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1086\/500511","volume":"193","year":"2006","unstructured":"Mueller, J. E., S. Yaro, Y. Traore, L. Sangare, Z. Tarnagda, B. M. Njanpop-Lafourcade, R. Borrow, and B. D. Gessner. 2006. Neisseria meningitidis serogroups A and W-135: carriage and immunity in Burkina Faso, 2003. J. Infect. Dis.193:812-820.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_42_2","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3201\/eid0705.010513","volume":"7","year":"2001","unstructured":"Nicolas, P., L. Decousset, V. Riglet, P. Castelli, R. Stor, and G. Blanchet. 2001. Clonal expansion of sequence type (ST-)5 and emergence of ST-7 in serogroup A meningococci, Africa. Emerg. Infect. Dis.7:849-854.","journal-title":"Emerg. Infect. Dis."},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.10.5129-5135.2005"},{"key":"e_1_3_2_44_2","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1016\/j.vaccine.2005.02.021","volume":"23","year":"2005","unstructured":"Norheim, G., A. Aase, D. A. Caugant, E. A. H\u00f8iby, E. Fritzs\u00f8nn, T. Tangen, P. Kristiansen, U. Heggelund, and E. Rosenqvist. 2005. Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis. Vaccine23:3762-3774.","journal-title":"Vaccine"},{"key":"e_1_3_2_45_2","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/j.vaccine.2003.11.047","volume":"22","year":"2004","unstructured":"Norheim, G., E. A. H\u00f8iby, D. A. Caugant, E. Namork, T. Tangen, E. Fritzs\u00f8nn, and E. Rosenqvist. 2004. Immunogenicity and bactericidal activity in mice of an outer membrane protein vesicle vaccine against Neisseria meningitidis serogroup A disease. Vaccine22:2171-2180.","journal-title":"Vaccine"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.44.3.861-871.2006"},{"key":"e_1_3_2_47_2","doi-asserted-by":"crossref","unstructured":"Patel M. and C. K. Lee. 2005. Polysaccharide vaccines for preventing serogroup A meningococcal meningitis. Cochrane Database Syst. Rev. 2005: CD001093.","DOI":"10.1002\/14651858.CD001093.pub2"},{"key":"e_1_3_2_48_2","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1056\/NEJM197709292971302","volume":"297","year":"1977","unstructured":"Peltola, H., H. Makela, H. Kayhty, H. Jousimies, E. Herva, K. Hallstrom, A. Sivonen, O. V. Renkonen, O. Pettay, V. Karanko, P. Ahvonen, and S. Sarna. 1977. Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. N. Engl. J. Med.297:686-691.","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.5.2441-2451.1999"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1128\/cdli.2.1.69-72.1995"},{"key":"e_1_3_2_51_2","first-page":"111","volume":"43","year":"1991","unstructured":"Rao, B., A. Ayyagari, and M. Sharma. 1991. Evaluation of antibody response in meningococcal patients, contacts and vaccinees in north India. Trop. Geogr. Med.43:111-113.","journal-title":"Trop. Geogr. Med."},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.6.5.651-656.1972"},{"key":"e_1_3_2_53_2","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/00006454-200010000-00001","volume":"19","year":"2000","unstructured":"Robbins, J. B., R. Schneerson, and E. C. Gotschlich. 2000. A rebuttal: epidemic and endemic meningococcal meningitis in sub-Saharan Africa can be prevented now by routine immunization with group A meningococcal capsular polysaccharide vaccine. Pediatr. Infect. Dis. J.19:945-953.","journal-title":"Pediatr. Infect. Dis. J."},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.26.8.1543-1548.1988"},{"key":"e_1_3_2_55_2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1017\/S0950268800068242","volume":"110","year":"1993","unstructured":"Salih, M. A., H. Fredlund, S. Hugosson, L. Bodin, and P. Olcen. 1993. Different seroprevalences of antibodies against Neisseria meningitidis serogroup A and Haemophilus influenzae type b in Sudanese and Swedish children. Epidemiol. Infect.110:307-316.","journal-title":"Epidemiol. Infect."},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.8.3.616-623.2001"},{"key":"e_1_3_2_57_2","doi-asserted-by":"crossref","first-page":"676","DOI":"10.4269\/ajtmh.1991.45.676","volume":"45","year":"1991","unstructured":"Sippel, J. E., and N. I. Girgis. 1991. Detection of IgM antibodies to Neisseria meningitidis group A polysaccharide in meningitis patients by direct and antibody capture enzyme-linked immunosorbent assays. Am. J. Trop. Med. Hyg.45:676-682.","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"e_1_3_2_58_2","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1699-0463.1990.tb05035.x","volume":"98","year":"1990","unstructured":"Sjursen, H., E. Wedege, E. Rosenqvist, A. Naess, A. Halstensen, R. Matre, and C. O. Solberg. 1990. IgG subclass antibodies to serogroup B meningococcal outer membrane antigens following infection and vaccination. APMIS98:1061-1069.","journal-title":"APMIS"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.48.1.23-28.1985"},{"key":"e_1_3_2_60_2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2958.1994.tb01014.x","volume":"12","year":"1994","unstructured":"Suker, J., I. M. Feavers, M. Achtman, G. Morelli, J. F. Wang, and M. C. Maiden. 1994. The porA gene in serogroup A meningococci: evolutionary stability and mechanism of genetic variation. Mol. Microbiol.12:253-265.","journal-title":"Mol. Microbiol."},{"key":"e_1_3_2_61_2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0264-410X(96)00138-7","volume":"15","year":"1997","unstructured":"Thiesen, B., B. Greenwood, N. Brieske, and M. Achtman. 1997. Persistence of antibodies to meningococcal IgA1 protease versus decay of antibodies to group A polysaccharide and Opc protein. Vaccine15:209-219.","journal-title":"Vaccine"},{"key":"e_1_3_2_62_2","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.4049\/jimmunol.166.10.6250","volume":"166","year":"2001","unstructured":"Vidarsson, G., W. L. Der Pol, J. M. van Den Elsen, H. Vile, M. Jansen, J. Duijs, H. C. Morton, E. Boel, M. R. Daha, B. Corthesy, and J. G. van de Winkel. 2001. Activity of human IgG and IgA subclasses in immune defense against Neisseria meningitidis serogroup B. J. Immunol.166:6250-6256.","journal-title":"J. Immunol."},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.29.7.1486-1492.1991"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.7.3223-3231.1998"},{"key":"e_1_3_2_65_2","unstructured":"World Health Organization. 1999. Standardization and validation of serological assays for the evaluation of immune responses to Neisseria meningitidis serogroup A\/C vaccines. Document no. WHO\/V&B\/99.19. Vaccine Development Team Department of Vaccines and Biologicals World Health Organization Geneva Switzerland."},{"key":"e_1_3_2_66_2","first-page":"41","year":"2001","unstructured":"Yang, Q., and H. Jennings. 2001. Purification of capsular polysaccharide, p. 41-48. In A. J. Pollard and M. C. Maiden (ed.), Methods in molecular medicine. Meningococcal vaccines: methods and protocols. Humana Press, Totowa, NJ.","journal-title":"Methods in molecular medicine"},{"key":"e_1_3_2_67_2","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/infdis\/169.4.847","volume":"169","year":"1994","unstructured":"Zangwill, K. M., R. W. Stout, G. M. Carlone, L. Pais, H. Harekeh, S. Mitchell, W. H. Wolfe, V. Blackwood, B. D. Plikaytis, and J. D. Wenger. 1994. Duration of antibody response after meningococcal polysaccharide vaccination in US Air Force personnel. J. Infect. Dis.169:847-852.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_68_2","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1073\/pnas.061386098","volume":"98","year":"2001","unstructured":"Zhu, P., A. van der Ende, D. Falush, N. Brieske, G. Morelli, B. Linz, T. Popovic, I. G. Schuurman, R. A. Adegbola, K. Zurth, S. Gagneux, A. E. Platonov, J. Y. Riou, D. A. Caugant, P. Nicolas, and M. Achtman. 2001. Fit genotypes and escape variants of subgroup III Neisseria meningitidis during three pandemics of epidemic meningitis. Proc. Natl. Acad. Sci. USA98:5234-5239.","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00008-07","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00008-07","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T23:39:40Z","timestamp":1707608380000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00008-07"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["10.1128\/CVI.00008-07"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00008-07","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4]]},"assertion":[{"value":"2006-10-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-02-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}